share_log

Aprea Therapeutics: Q2 Earnings Insights

Benzinga Real-time News ·  Aug 12, 2022 09:48

Aprea Therapeutics (NASDAQ:APRE) reported its Q2 earnings results on Friday, August 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Aprea Therapeutics posted an EPS of $-0.99.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 29.68% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Aprea Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment